The funds were raised led by pi Ventures with participation from Ankur Capital, Axilor Ventures, 500 Startups and Flipkart co-founder Binny Bansal
NIRAMAI Health Analytix, a startup that is building a revolutionary non-invasive, non-touch, non-radiation approach to detect breast cancer has raised seed funding led by pi Ventures with participation from Ankur Capital, Axilor Ventures, 500 Startups and Flipkart co-founder Binny Bansal. NIRAMAI (Non Invasive Risk Assessment with Machine Learning) is a pioneer of a new patented technology called Thermalytix that can remove technological, logistical, and cultural barriers that hinder breast cancer screening among women today. The start-up’s solution uses artificial intelligence over thermal images to address the issues of early detection of breast cancer.
NIRAMAI is on a mission to create a universal cancer screening method that can save lives by detecting breast cancer at an early stage. The overall hardware-software solution is portable and uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. Early diagnosis is critical in saving the life of a cancer patient. Their method of screening is based on principles of Thermography that can detect tumours five years before mammography or a clinical exam can detect.
Dr Geetha Manjunath, CEO and Co-founder of NIRAMAI, says, “Mortality rates among breast cancer patients are very high in India. Our solution is portable, low-cost, very safe, privacy-sensitive and can detect cancer at a very early stage making it very suitable for regular preventive health checkup as well as screening camps. This investment will help us strengthen our IP portfolio, expand operations and ensure our cancer screening tool is readily available for commercial use.”